Roflumilast

COPD Maintenance

The oral form of roflumilast is used to reduce the risk of worsening symptoms, known as exacerbations, in adults with severe chronic obstructive pulmonary disease (COPD). It is specifically indicated for patients who have chronic bronchitis and a history of frequent flare-ups. This medication is intended for long-term maintenance and is not a rescue inhaler; it will not stop a sudden breathing emergency or an acute asthma attack.

Skin Conditions

Roflumilast is also available in topical forms, such as creams and foams, to treat inflammatory skin disorders in adults and children of certain ages:

• Plaque Psoriasis: The cream is used to treat plaque psoriasis, including in intertriginous areas where skin surfaces rub together, such as the armpits or groin.
• Seborrheic Dermatitis: The foam is used to treat seborrheic dermatitis on the scalp and other parts of the body.

Mechanism of Action

Roflumilast belongs to a class of medications known as phosphodiesterase-4 (PDE4) inhibitors. It works by blocking the action of an enzyme called PDE4, which is found in various cells throughout the body, including those involved in the immune system and inflammatory responses.

Reducing Inflammation

When the PDE4 enzyme is blocked, levels of a natural substance called cyclic adenosine monophosphate (cAMP) increase within the cells. Higher levels of cAMP help to:

• Decrease the production of inflammatory chemicals.
• Reduce the activity of immune cells that cause swelling and irritation.

How It Helps Specific Conditions

The way roflumilast helps depends on how it is administered:

• For Lung Conditions: When taken orally for chronic obstructive pulmonary disease (COPD), it helps reduce inflammation in the airways. This can prevent the sudden worsening of symptoms, known as exacerbations, in people with severe COPD associated with chronic bronchitis.
• For Skin Conditions: When applied topically as a cream or foam, it targets inflammation directly at the site of skin issues like plaque psoriasis or seborrheic dermatitis. This helps clear up red, scaly, or itchy patches by calming the overactive immune response in the skin.

Common Side Effects

When taken orally, common side effects may include:

• Diarrhea
• Nausea
• Weight loss
• Headache
• Back pain
• Dizziness
• Difficulty falling asleep or staying asleep
• Decreased appetite
• Flu-like symptoms

When applied topically to the skin, common side effects may include:

• Redness, itching, or pain at the application site
• Skin irritation

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious side effects while taking oral roflumilast:

• Changes in mood or behavior, such as depression, anxiety, or suicidal thoughts
• Unexplained or rapid weight loss
• Tremors or uncontrollable shaking of a part of the body

For topical roflumilast, seek medical attention for:

• Severe skin reactions
• Signs of an allergic reaction, such as hives, swelling of the face or throat, or difficulty breathing

Psychiatric Concerns

Treatment with roflumilast has been linked to an increased risk of psychiatric adverse events. These may include:

• Depression
• Anxiety
• Insomnia
• Suicidal thoughts or behavior

Caregivers and patients should remain alert for any new or worsening mood changes or unusual behaviors. If these symptoms occur, a healthcare provider should be notified immediately.

Weight Monitoring

Significant weight loss is a known risk associated with roflumilast. Healthcare providers typically monitor a patient's weight regularly during treatment. If unexplained or significant weight loss is observed, the clinical benefit of continuing the medication may need to be re-evaluated.

Liver Function

Roflumilast is contraindicated in patients with moderate to severe liver impairment (Child-Pugh Class B or C). Because the drug is processed by the liver, impaired function can lead to higher concentrations of the medication in the body, increasing the risk of side effects.

Acute Use

This medication is not a rescue treatment and will not provide immediate relief for acute bronchospasm or sudden breathing difficulties. It is designed for daily, long-term use to manage chronic conditions rather than for emergency symptom relief.

Drug Interactions

The use of strong cytochrome P450 enzyme inducers, such as rifampin, phenobarbital, or carbamazepine, is generally not recommended. These medications can significantly decrease the levels of roflumilast in the blood, potentially making it less effective.

Pregnancy

There are no adequate or well-controlled studies on the use of roflumilast in pregnant women. In animal studies, oral administration of the drug was associated with adverse effects, including reduced fetal weight and an increased risk of stillbirth at high doses. Roflumilast is not recommended for use during labor and delivery.

Breastfeeding

It is unknown whether roflumilast passes into human breast milk. Research in animals has shown that the drug and its active components are excreted in the milk of lactating rats. Because of the potential for serious side effects in a nursing infant, a decision should be made with a healthcare provider to either stop breastfeeding or stop taking the medication.

Consultation

If you are pregnant, planning to become pregnant, or are breastfeeding, talk to your healthcare provider about the potential risks and benefits of using roflumilast. They can help determine if the benefits of the medication outweigh the potential risks to the fetus or infant.

Oral Tablets

Roflumilast is primarily administered as an oral tablet. It is typically available in strengths intended for once-daily dosing. In some cases, a lower strength may be used during the first few weeks of treatment to improve tolerability before increasing to the standard dose.

Topical Preparations

For the treatment of skin conditions, roflumilast is available in the following topical forms:

• Cream: This form is applied to the skin to treat conditions like plaque psoriasis or atopic dermatitis.
• Foam: This formulation is used for skin conditions such as seborrheic dermatitis, particularly on the scalp or other hair-bearing areas.

FDA Approval Status

Roflumilast was first approved by the U.S. Food and Drug Administration (FDA) in 2011 as an oral tablet. The FDA has since approved topical formulations, including a cream and a foam, for various dermatological conditions.

Approved Indications

The FDA has approved roflumilast for several specific uses:

• Chronic Obstructive Pulmonary Disease (COPD): The oral tablet is used to reduce the frequency of flare-ups (exacerbations) in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.
• Plaque Psoriasis: The topical cream is approved for treating plaque psoriasis, including intertriginous psoriasis (psoriasis in skin folds), in adults and pediatric patients.
• Seborrheic Dermatitis: The topical foam is approved for the treatment of seborrheic dermatitis in adults and pediatric patients.

Regulatory Safety Information

There are no boxed warnings or Risk Evaluation and Mitigation Strategy (REMS) requirements for roflumilast. However, the FDA has issued safety communications regarding potential psychiatric risks. Labeling for the oral medication includes warnings about the risk of suicidal ideation and behavior, as well as weight loss. Patients are typically monitored for changes in mood, depression, or anxiety during treatment.

Factors Influencing Cost

The price of roflumilast can vary significantly based on several factors:

• Formulation: Roflumilast is available as an oral tablet and a topical cream. These different delivery methods have different pricing structures.
• Generic vs. Brand Name: Generic versions of the oral tablets are available, which are typically more affordable than the brand-name version. The topical cream may only be available as a brand-name product.
• Insurance Coverage: Most insurance plans, including Medicare Part D, provide coverage for the generic oral tablets. However, the topical formulation may be placed on a higher cost tier or require prior authorization from a healthcare provider.

Ways to Reduce Out-of-Pocket Expenses

Patients may be able to lower their costs through the following methods:

• Pharmacy Comparison: Prices for the same medication can vary between different retail pharmacies.
• Manufacturer Programs: For brand-name products, manufacturers sometimes offer savings cards or patient assistance programs for eligible individuals.
• Generic Substitution: When appropriate, using the generic oral tablet instead of the brand-name equivalent can reduce costs.